HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BCG versus thiotepa in non-CIS, stage Ta, T1 bladder cancer: rationale and design of ECOG trial.

AuthorsH A Fisher
JournalProgress in clinical and biological research (Prog Clin Biol Res) Vol. 310 Pg. 275-83 ( 1989) ISSN: 0361-7742 [Print] United States
PMID2505271 (Publication Type: Clinical Trial, Journal Article, Multicenter Study, Review)
Chemical References
  • BCG Vaccine
  • Mitomycins
  • Doxorubicin
  • Thiotepa
Topics
  • Aged
  • BCG Vaccine (therapeutic use)
  • Carcinoma in Situ (drug therapy, therapy)
  • Carcinoma, Transitional Cell (drug therapy, therapy)
  • Doxorubicin (therapeutic use)
  • Female
  • Humans
  • Male
  • Mitomycins (therapeutic use)
  • Multicenter Studies as Topic
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Thiotepa (therapeutic use)
  • Urinary Bladder Neoplasms (drug therapy, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: